Formycon AG (LTS:0W4N) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0W4N Formycon AG LTS:0W4N
57 GF Score
Price €17.98
GF Value €37.25
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Formycon AG Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0W4N vs VRTX, REGN, ALNY: Short Percentage of Float Comparison

For the Biotechnology subindustry, Formycon AG's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Formycon AG Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Formycon AG's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Formycon AG's Short Percentage of Float falls into.


LTS:0W4N
57GF Score
Formycon AG LTS:0W4N
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Formycon AG (LTS:0W4N) Overvalued in 2026?

Based on GuruFocus' analysis, Formycon AG stock appears to be undervalued. The current stock price of €17.98 is trading 51.7% below its estimated GF Value™ of €37.25. GuruFocus considers Formycon AG to be Possible Value Trap.

Key valuation signals for LTS:0W4N:

  • Short Percentage of Float:
  • GF Value™: €37.25 vs. price of €17.98 (51.7% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the LTS:0W4N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Formycon AG Business Description

Other Exchanges FYB:GermanyFYB:Austria
Address Fraunhoferstrasse 15, Martinsried, Planegg, BY, DEU, 82152
Formycon AG is an independent developer of high-quality biosimilars, which are follow-on products to biopharmaceutical drugs. The Company focuses on expanding and further developing its scalable biosimilar platform, which includes approved and pipeline products across ophthalmology, immunology, and immuno-oncology. Its key products include FYB201 (ranibizumab), FYB202 (ustekinumab), FYB203 (aflibercept), FYB206 (pembrolizumab), and FYB208 (dupilumab), along with additional biosimilar candidates in various stages of development. The Company generates maximum revenue from Switzerland.
57GF Score

Get the complete analysis for LTS:0W4N

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.98
Price
€37.25
GF Value